Electromed, Inc.

ELMD ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $73.8M $64.0M $54.7M $48.1M $41.7M $35.8M $32.5M $31.3M
Cost of Revenue $15.8M $14.0M $13.0M $11.5M $10.2M $8.5M $7.3M $7.5M
Gross Profit $57.9M $50.0M $41.7M $36.5M $31.4M $27.3M $25.2M $23.8M
Gross Margin 78.5% 78.1% 76.3% 76.0% 75.5% 76.4% 77.6% 76.2%
Operating Expenses
Research & Development $1.3M $996.0K $656.0K $916.0K $1.4M $1.7M $1.1M $583.3K
SG&A Expense $42.7M $39.3M $34.5M $31.6M $27.1M $22.4M $19.9M $20.4M
Operating Income $13.9M $9.7M $6.6M $4.0M $3.0M $3.1M $5.1M $2.8M
Operating Margin 18.8% 15.1% 12.0% 8.3% 7.1% 8.8% 15.8% 9.0%
Interest Expense
Pretax Income $14.4M $10.3M $7.0M $4.1M $3.0M $3.2M $5.2M $2.9M
Income Tax Expense $3.1M $2.7M $1.9M $920.0K $692.0K $805.0K $1.1M $940.0K
Net Income $11.3M $7.5M $5.2M $3.2M $2.3M $2.4M $4.2M $2.0M
Net Margin 15.3% 11.8% 9.4% 6.6% 5.5% 6.6% 12.8% 6.3%
EPS (Basic) $1.37 $0.89 $0.60 $0.37 $0.27 $0.28 $0.50 $0.24
EPS (Diluted) $1.30 $0.85 $0.58 $0.36 $0.26 $0.27 $0.47 $0.23
Shares Outstanding (Basic) 8.3M 8.5M 8.6M 8.5M 8.5M 8.6M 8.4M 8.3M
Shares Outstanding (Diluted) 8.7M 8.9M 8.9M 8.7M 8.8M 8.9M 8.8M 8.6M
Dividends Per Share
← Newer Page 1 of 2 Older →